|
CN1299358A
(zh)
*
|
1997-12-31 |
2001-06-13 |
新泽西州州立大学(拉特格斯) |
杂环拓扑异构酶毒性剂
|
|
IL137351A0
(en)
|
1998-02-12 |
2001-07-24 |
Univ Rutgers |
Heterocyclic topoisomerase poisons
|
|
WO2000076556A2
(en)
*
|
1999-06-11 |
2000-12-21 |
Neorx Corporation |
High dose radionuclide complexes for bone marrow suppression
|
|
US7094885B2
(en)
*
|
1999-07-11 |
2006-08-22 |
Neorx Corporation |
Skeletal-targeted radiation to treat bone-associated pathologies
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
JP2004536034A
(ja)
|
2001-01-08 |
2004-12-02 |
ネオルクス コーポレイション |
治療的および診断的化合物、組成物および方法
|
|
AU2002363658B2
(en)
*
|
2001-11-14 |
2008-09-11 |
Rutgers, The State University |
Solubilized topoisomerase poisons
|
|
CA2467279A1
(en)
*
|
2001-11-14 |
2003-06-26 |
Edmond J. Lavoie |
Solubilized topoisomerase poison agents
|
|
ATE405568T1
(de)
*
|
2001-11-14 |
2008-09-15 |
Univ Rutgers |
Cytotoxische mittel
|
|
DE60225943T2
(de)
*
|
2001-11-14 |
2009-01-29 |
Rutgers, The State University |
Topoisomerase-giftmittel
|
|
EP1458416A1
(en)
|
2001-12-13 |
2004-09-22 |
Dow Global Technologies Inc. |
Treatment of osteomyelitis with radiopharmaceuticals
|
|
AU2003268075A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Edmond J. Lavoie |
Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
|
|
US6992088B2
(en)
*
|
2002-08-09 |
2006-01-31 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted heterocycles as topoisomerase I targeting agents
|
|
US6989387B2
(en)
*
|
2002-08-09 |
2006-01-24 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
|
AU2003290818A1
(en)
*
|
2002-11-12 |
2004-06-03 |
Edmond J. Lavoie |
Topoisomerase-targeting agents
|
|
GB0619325D0
(en)
|
2006-09-30 |
2006-11-08 |
Univ Strathclyde |
New compounds
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
JP5773888B2
(ja)
|
2009-03-06 |
2015-09-02 |
ラットガーズ，ザ・ステート・ユニバーシティ・オブ・ニュージャージー |
癌治療に用いられるメチレンジオキシベンゾ［ｉ］フェナントリジン誘導体
|
|
WO2010127363A1
(en)
|
2009-05-01 |
2010-11-04 |
Rutgers, The State University Of New Jersey |
Toposiomerase inhibitors
|
|
CA2801274C
(en)
*
|
2010-06-01 |
2021-06-15 |
Summit Corporation Plc |
Compounds for the treatment of clostridium difficile-associated disease
|
|
US9920014B2
(en)
|
2013-09-19 |
2018-03-20 |
The Florida International University Board Of Trustees |
Selective inhibition of bacterial topoisomerase I
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
CA3011672C
(en)
|
2016-01-23 |
2022-11-01 |
Vibha Tandon |
Broad spectrum antibacterial activity of bisbenzimidazoles targeting topoisomerase ia
|
|
EP3442979A4
(en)
|
2016-04-04 |
2019-12-18 |
Rutgers, the State University of New Jersey |
topoisomerase poisons
|
|
JP7267563B2
(ja)
|
2017-06-27 |
2023-05-02 |
株式会社Kyulux |
発光材料、化合物、遅延蛍光体および発光素子
|
|
WO2019004254A1
(ja)
|
2017-06-27 |
2019-01-03 |
株式会社Ｋｙｕｌｕｘ |
発光材料、化合物、遅延蛍光体および発光素子
|